Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
MousePheno	abnormal ear physiology	ERCC6 PRRC2C POLG EIF4B COBL FGFR1 BSN KIF13A ANKFN1 FRMD3 SLC4A2 COL1A1	2.30e-05	684	59	12	MP:0003878
Domain	FIBRINOGEN_C_1	CNTNAP3B TNC CNTNAP3	2.31e-04	32	70	3	PS00514
Domain	Fibrinogen_a/b/g_C_dom	CNTNAP3B TNC CNTNAP3	2.31e-04	32	70	3	IPR002181
Domain	FIBRINOGEN_C_2	CNTNAP3B TNC CNTNAP3	2.31e-04	32	70	3	PS51406
Domain	fn3	CHL1 PTPRD TNC NCAM1 ANKFN1	3.55e-04	162	70	5	PF00041
Domain	LAM_G_DOMAIN	CNTNAP3B FAT4 CNTNAP3	3.87e-04	38	70	3	PS50025
Domain	Laminin_G_2	CNTNAP3B FAT4 CNTNAP3	4.51e-04	40	70	3	PF02210
Domain	LamG	CNTNAP3B FAT4 CNTNAP3	5.98e-04	44	70	3	SM00282
Domain	FN3	CHL1 PTPRD TNC NCAM1 ANKFN1	6.49e-04	185	70	5	SM00060
Domain	FERM_central	TYK2 PTPN13 FRMD3	8.21e-04	49	70	3	IPR019748
Domain	FERM_domain	TYK2 PTPN13 FRMD3	8.21e-04	49	70	3	IPR000299
Domain	FERM_1	TYK2 PTPN13 FRMD3	8.71e-04	50	70	3	PS00660
Domain	FERM_2	TYK2 PTPN13 FRMD3	8.71e-04	50	70	3	PS00661
Domain	FERM_3	TYK2 PTPN13 FRMD3	8.71e-04	50	70	3	PS50057
Domain	Band_41_domain	TYK2 PTPN13 FRMD3	8.71e-04	50	70	3	IPR019749
Domain	B41	TYK2 PTPN13 FRMD3	8.71e-04	50	70	3	SM00295
Domain	FN3	CHL1 PTPRD TNC NCAM1 ANKFN1	9.02e-04	199	70	5	PS50853
Domain	FN3_dom	CHL1 PTPRD TNC NCAM1 ANKFN1	1.12e-03	209	70	5	IPR003961
Domain	Ig-like_fold	CHL1 PTPRD HLA-B TNC NCAM1 REL FGFR1 ANKFN1 SLC4A2	1.24e-03	706	70	9	IPR013783
Domain	Laminin_G	CNTNAP3B FAT4 CNTNAP3	1.34e-03	58	70	3	IPR001791
Domain	EGF_3	CNTNAP3B FAT4 TNC HBEGF CNTNAP3	1.88e-03	235	70	5	PS50026
Domain	EGF	CNTNAP3B FAT4 TNC HBEGF CNTNAP3	1.88e-03	235	70	5	SM00181
Domain	EGF-like_dom	CNTNAP3B FAT4 TNC HBEGF CNTNAP3	2.42e-03	249	70	5	IPR000742
Domain	EGF_1	CNTNAP3B FAT4 TNC HBEGF CNTNAP3	2.68e-03	255	70	5	PS00022
Domain	FA58C	CNTNAP3B CNTNAP3	2.78e-03	21	70	2	SM00231
Domain	FA58C_3	CNTNAP3B CNTNAP3	2.78e-03	21	70	2	PS50022
Domain	FA58C_1	CNTNAP3B CNTNAP3	2.78e-03	21	70	2	PS01285
Domain	FA58C_2	CNTNAP3B CNTNAP3	2.78e-03	21	70	2	PS01286
Domain	EGF_2	CNTNAP3B FAT4 TNC HBEGF CNTNAP3	3.16e-03	265	70	5	PS01186
Domain	-	CHL1 PTPRD HLA-B TNC NCAM1 REL FGFR1 ANKFN1	3.28e-03	663	70	8	2.60.40.10
Domain	F5_F8_type_C	CNTNAP3B CNTNAP3	3.62e-03	24	70	2	PF00754
Domain	FA58C	CNTNAP3B CNTNAP3	3.62e-03	24	70	2	IPR000421
Domain	FERM_C	PTPN13 FRMD3	4.25e-03	26	70	2	PF09380
Domain	FERM_C	PTPN13 FRMD3	4.57e-03	27	70	2	SM01196
Domain	FERM_PH-like_C	PTPN13 FRMD3	4.57e-03	27	70	2	IPR018980
Domain	FBG	TNC CNTNAP3	5.27e-03	29	70	2	SM00186
Domain	-	TNC CNTNAP3	5.63e-03	30	70	2	3.90.215.10
Domain	Fibrinogen_a/b/g_C_1	TNC CNTNAP3	5.63e-03	30	70	2	IPR014716
Domain	Ig_I-set	CHL1 PTPRD NCAM1 FGFR1	5.64e-03	190	70	4	IPR013098
Domain	ig	CHL1 PTPRD NCAM1 FGFR1	5.64e-03	190	70	4	PF00047
Domain	Immunoglobulin	CHL1 PTPRD NCAM1 FGFR1	5.64e-03	190	70	4	IPR013151
Domain	I-set	CHL1 PTPRD NCAM1 FGFR1	5.64e-03	190	70	4	PF07679
Domain	SNF2_N	ERCC6 CHD4	6.39e-03	32	70	2	IPR000330
Domain	SNF2_N	ERCC6 CHD4	6.39e-03	32	70	2	PF00176
Domain	FERM_N	PTPN13 FRMD3	6.78e-03	33	70	2	PF09379
Domain	FERM_N	PTPN13 FRMD3	6.78e-03	33	70	2	IPR018979
Pubmed	BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.	GOPC EIF4B BOP1 REL GPATCH8 CDC25A HNRNPU	4.59e-07	226	72	7	25900982
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	CYC1 ATP6V1H HLA-B ZNF280C FAM20B NCAM1 CHD4 GPATCH8 ZCCHC7 ZNF317 ZNF417 NDUFB8 HNRNPU	1.01e-06	1203	72	13	29180619
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	TES AGL POLG ZNF280C CHD4 MIB2 FGFR1 KIF13A HNRNPU SLC4A2 DNMT3B	3.06e-06	925	72	11	28986522
Pubmed	Adhesion molecules close homolog of L1 and tenascin-C affect blood-spinal cord barrier repair.	CHL1 TNC	4.23e-06	2	72	2	22473292
Pubmed	Long noncoding RNA GMAN promotes hepatocellular carcinoma progression by interacting with eIF4B.	PPP2R2A EIF4B	4.23e-06	2	72	2	31875526
Pubmed	Neural cell adhesion molecule stimulates survival of premyelinating oligodendrocytes via the fibroblast growth factor receptor.	NCAM1 FGFR1	4.23e-06	2	72	2	19739251
Pubmed	NCAM-mimetic, FGL peptide, restores disrupted fibroblast growth factor receptor (FGFR) phosphorylation and FGFR mediated signaling in neural cell adhesion molecule (NCAM)-deficient mice.	NCAM1 FGFR1	4.23e-06	2	72	2	19909731
Pubmed	Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor.	NCAM1 FGFR1	4.23e-06	2	72	2	18042627
Pubmed	Costimulation of T cell receptor-triggered IL-2 production by Jurkat T cells via fibroblast growth factor receptor 1 upon its engagement by CD56.	NCAM1 FGFR1	4.23e-06	2	72	2	12121226
Pubmed	The NCAM1 gene set is linked to depressive symptoms and their brain structural correlates in healthy individuals.	NCAM1 COL1A1	4.23e-06	2	72	2	28334615
Pubmed	Caspr3-Deficient Mice Exhibit Low Motor Learning during the Early Phase of the Accelerated Rotarod Task.	CNTNAP3B CNTNAP3	4.23e-06	2	72	2	26807827
Pubmed	Depression-like behaviour in neural cell adhesion molecule (NCAM)-deficient mice and its reversal by an NCAM-derived peptide, FGL.	NCAM1 FGFR1	4.23e-06	2	72	2	18973581
Pubmed	NCAM-derived peptides function as agonists for the fibroblast growth factor receptor.	NCAM1 FGFR1	4.23e-06	2	72	2	18624916
Pubmed	Stress downregulates hippocampal expression of the adhesion molecules NCAM and CHL1 in mice by mechanisms independent of DNA methylation of their promoters.	CHL1 NCAM1	4.23e-06	2	72	2	19262122
Pubmed	Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1.	CHL1 NCAM1	4.23e-06	2	72	2	12391163
Pubmed	Modulation of NCAM/FGFR1 signaling suppresses EMT program in human proximal tubular epithelial cells.	NCAM1 FGFR1	4.23e-06	2	72	2	30383875
Pubmed	Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP.	NCAM1 FGFR1	4.23e-06	2	72	2	12791257
Pubmed	The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice.	CNTNAP3B CNTNAP3	4.23e-06	2	72	2	31150793
Pubmed	The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling.	NCAM1 FGFR1	4.23e-06	2	72	2	21739604
Pubmed	Spatial and temporal expression of molecular markers and cell signals during normal development of the mouse patellar tendon.	TNC FGFR1 COL1A1	4.67e-06	16	72	3	21939397
Pubmed	Targeted inhibition of ubiquitin signaling reverses metabolic reprogramming and suppresses glioblastoma growth.	CYC1 PPP2R2A ATP6V1H PDHA1	5.72e-06	56	72	4	35918402
Pubmed	The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule.	NCAM1 FGFR1	1.27e-05	3	72	2	17005551
Pubmed	Organization and reorganization of neuromuscular junctions in mice lacking neural cell adhesion molecule, tenascin-C, or fibroblast growth factor-5.	TNC NCAM1	1.27e-05	3	72	2	9454855
Pubmed	Structure of the tandem fibronectin type 3 domains of neural cell adhesion molecule.	NCAM1 FGFR1	1.27e-05	3	72	2	18261743
Pubmed	Tumor cell invasion of von Hippel Lindau renal cell carcinoma cells is mediated by membrane type-1 matrix metalloproteinase.	EPAS1 COL1A1	1.27e-05	3	72	2	17140440
Pubmed	Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism.	PDHA1 FGFR1	1.27e-05	3	72	2	22195962
Pubmed	NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells.	NCAM1 FGFR1	1.27e-05	3	72	2	27317650
Pubmed	Increased DNA methylation of Dnmt3b targets impairs leukemogenesis.	DNMT3B COL1A1	1.27e-05	3	72	2	26729896
Pubmed	Investigation of the Sp1-binding site polymorphism within the COL1A1 gene in participants with Achilles tendon injuries and controls.	TNC COL1A1	1.27e-05	3	72	2	18353721
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	CHL1 PLXDC2 TNC NCAM1 FGFR1 PLTP	1.60e-05	257	72	6	16335952
Pubmed	Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool.	FAT4 TNC NCAM1	1.67e-05	24	72	3	26116661
Pubmed	Proteomic Analysis of the Spinophilin Interactome in Rodent Striatum Following Psychostimulant Sensitization.	PPP2R2A ATP6V1H PDHA1 GLUL NCAM1 BSN HNRNPU	2.05e-05	403	72	7	30562941
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	MPP2 GOPC PDHA1 PRRC2C EIF4B GLUL NCAM1 MIB2 BSN SNRNP70 HNRNPU	2.15e-05	1139	72	11	36417873
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	MAGEA4 PPP2R2A ATP6V1H MYG1 HLA-B AGL EIF4B BOP1 CHD4 PHLDB2 HNRNPU COL1A1	2.24e-05	1367	72	12	32687490
Pubmed	An in situ hybridization study of decorin and biglycan mRNA in mouse osteoblasts in vivo.	TNC COL1A1	2.53e-05	4	72	2	33219434
Pubmed	A potential role for the OTX2 homeoprotein in creating early 'highways' for axon extension in the rostral brain.	TNC NCAM1	2.53e-05	4	72	2	9753681
Pubmed	DNMT3B Oncogenic Activity in Human Intestinal Cancer Is Not Linked to CIMP or BRAFV600E Mutation.	DNMT3B COL1A1	2.53e-05	4	72	2	32058953
Pubmed	The aged niche disrupts muscle stem cell quiescence.	FGFR1 COL1A1	2.53e-05	4	72	2	23023126
Pubmed	Rel-Dependent Immune and Central Nervous System Mechanisms Control Viral Replication and Inflammation during Mouse Herpes Simplex Encephalitis.	REL UNC93B1	2.53e-05	4	72	2	30683700
Pubmed	Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing.	DNMT3B COL1A1	2.53e-05	4	72	2	18056424
Pubmed	Tenascin-C is an inhibitory boundary molecule in the developing olfactory bulb.	TNC NCAM1	2.53e-05	4	72	2	19641104
Pubmed	The neural cell adhesion molecule promotes FGFR-dependent phosphorylation and membrane targeting of the exocyst complex to induce exocytosis in growth cones.	NCAM1 FGFR1	2.53e-05	4	72	2	21389209
Pubmed	Hypoxia-inducible factor prolyl-4-hydroxylation in FOXD1 lineage cells is essential for normal kidney development.	NCAM1 EPAS1 COL1A1	2.69e-05	28	72	3	28847650
Pubmed	Functional proteomics mapping of a human signaling pathway.	ERCC6 MYG1 HLA-B GLUL ZCCHC7 SNRNP70 KIF13A EPAS1	3.05e-05	591	72	8	15231748
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CYC1 MPP2 PPP2R2A ATP6V1H PDHA1 TNC PRRC2C EIF4B GLUL NCAM1 BSN HNRNPU	3.51e-05	1431	72	12	37142655
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PPP2R2A ATP6V1H TES MYG1 GOPC PDHA1 AGL EIF4B GLUL BOP1 KIF13A HNRNPU	4.12e-05	1455	72	12	22863883
Pubmed	Pseudosubstrate regulation of the SCF(beta-TrCP) ubiquitin ligase by hnRNP-U.	SNRNP70 HNRNPU	4.21e-05	5	72	2	11850407
Pubmed	The mouse homolog to the ras-related yeast gene YPT1 maps on chromosome 11 close to the wobbler (wr) locus.	GLUL REL	4.21e-05	5	72	2	1643310
Pubmed	Neutralizing Gatad2a-Chd4-Mbd3/NuRD Complex Facilitates Deterministic Induction of Naive Pluripotency.	CHD4 COL1A1	4.21e-05	5	72	2	30122475
Pubmed	IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase δ.	PTPRD BSN	4.21e-05	5	72	2	21940441
Pubmed	CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors.	CHD4 EPAS1	4.21e-05	5	72	2	32699137
Pubmed	Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.	PTPRD BSN	4.21e-05	5	72	2	22357843
Pubmed	Collagen and tenascin-C expression along the migration pathway of mouse primordial germ cells.	TNC COL1A1	4.21e-05	5	72	2	14758483
Pubmed	In trans neuregulin3-Caspr3 interaction controls DA axonal bassoon cluster development.	CNTNAP3B CNTNAP3	6.31e-05	6	72	2	34143959
Pubmed	Rewiring of the Human Mitochondrial Interactome during Neuronal Reprogramming Reveals Regulators of the Respirasome and Neurogenesis.	CYC1 TYK2 PTPRD HLA-B PDHA1 GLUL NDUFB8 COA7 HNRNPU	6.95e-05	859	72	9	31536960
Pubmed	Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.	TYK2 TNC REL BSN PLTP DNMT3B	7.83e-05	342	72	6	23128233
Pubmed	Sporadic Hirschsprung Disease: Mutational Spectrum and Novel Candidate Genes Revealed by Next-generation Sequencing.	PTPN13 AGL	8.82e-05	7	72	2	29093530
Pubmed	Smad3 binds Scleraxis and Mohawk and regulates tendon matrix organization.	TNC COL1A1	8.82e-05	7	72	2	23653374
Pubmed	A role for hedgehog signaling in the differentiation of the insertion site of the patellar tendon in the mouse.	TNC COL1A1	8.82e-05	7	72	2	23762363
Pubmed	Kruppel-like factor 4 expression in osteoblasts represses osteoblast-dependent osteoclast maturation.	TNC COL1A1	8.82e-05	7	72	2	24927920
Pubmed	Tenascin-C drives persistence of organ fibrosis.	TNC COL1A1	8.82e-05	7	72	2	27256716
Pubmed	Chondroitin sulfate N-acetylgalactosaminyltransferase-1 is required for normal cartilage development.	CSGALNACT2 FAM20B	8.82e-05	7	72	2	20812917
Pubmed	Direct binding of PP2A to Sprouty2 and phosphorylation changes are a prerequisite for ERK inhibition downstream of fibroblast growth factor receptor stimulation.	PPP2R2A FGFR1	8.82e-05	7	72	2	17255109
Pubmed	Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.	PDHA1 FGFR1	8.82e-05	7	72	2	24486017
Pubmed	Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin Dynamics.	ERCC6 CHD4 HNRNPU	9.89e-05	43	72	3	26030138
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	PLXDC2 PRRC2C EIF4B MIB2 SNRNP70 PHLDB2	1.05e-04	361	72	6	26167880
Pubmed	Increased Ca2+ signaling through CaV 1.2 induces tendon hypertrophy with increased collagen fibrillogenesis and biomechanical properties.	TNC COL1A1	1.17e-04	8	72	2	37261735
Pubmed	Reduced Dnmt3a increases Gdf5 expression with suppressed satellite cell differentiation and impaired skeletal muscle regeneration.	DNMT3B COL1A1	1.17e-04	8	72	2	29146735
Pubmed	The N-terminal domain of the Schaaf-Yang syndrome protein MAGEL2 likely has a role in RNA metabolism.	PRRC2C EIF4B HNRNPU	1.21e-04	46	72	3	34265304
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	CYC1 MPP2 ATP6V1H PDHA1 GLUL NCAM1 HNRNPU	1.48e-04	552	72	7	36293380
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	PTPN13 BOP1 CDC25A HNRNPU	1.48e-04	128	72	4	25332235
Pubmed	Evidence for lung barrier regeneration by differentiation prior to binucleated and stem cell division.	HBEGF COL1A1	1.51e-04	9	72	2	37843535
Pubmed	Tenascin C regulates proliferation and differentiation processes during embryonic retinogenesis and modulates the de-differentiation capacity of Müller glia by influencing growth factor responsiveness and the extracellular matrix compartment.	TNC GLUL	1.51e-04	9	72	2	22691363
Pubmed	Dynamic expression patterns of ECM molecules in the developing mouse olfactory pathway.	TNC NCAM1	1.51e-04	9	72	2	18570250
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	FAT4 EIF4B COBL NCAM1 SNRNP70	1.62e-04	246	72	5	15345747
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	MPP2 PTPRD PRRC2C GLUL NCAM1 CHD4 BSN PHLDB2 HNRNPU	1.65e-04	963	72	9	28671696
Pubmed	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	CHL1 TNC KIF13A	1.75e-04	52	72	3	22219177
Pubmed	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	CHL1 PTPRD NCAM1 CSMD1	1.77e-04	134	72	4	24324551
Pubmed	A COFRADIC protocol to study protein ubiquitination.	PDHA1 GLUL CHD4 HNRNPU	1.77e-04	134	72	4	24816145
Pubmed	Global identification of modular cullin-RING ligase substrates.	PDHA1 GLUL CHD4 HNRNPU	1.77e-04	134	72	4	21963094
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	PPP2R2A FAT4 CSGALNACT2 GOPC HLA-B FAM20B CNTNAP3 UNC93B1 SLC4A2 COL1A1	1.78e-04	1201	72	10	35696571
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	TYK2 PPP2R2A ATP6V1H PTPRD GOPC AGL GLUL BOP1 CDC25A	1.79e-04	974	72	9	28675297
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	TES MYG1 GOPC PRRC2C GPATCH8 SNRNP70	1.81e-04	399	72	6	35987950
Pubmed	Proteomic analysis of in vivo phosphorylated synaptic proteins.	PDHA1 NCAM1 BSN	1.85e-04	53	72	3	15572359
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	CYC1 CSGALNACT2 GOPC HLA-B PDHA1 GLUL CHD4 UNC93B1 NDUFB8 HNRNPU SLC4A2	1.87e-04	1451	72	11	30550785
Pubmed	Proteolytic cleavage of transmembrane cell adhesion molecule L1 by extracellular matrix molecule Reelin is important for mouse brain development.	CHL1 NCAM1	1.88e-04	10	72	2	29127326
Pubmed	Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis.	TYK2 BOP1	1.88e-04	10	72	2	35821088
Pubmed	Widespread neuronal ectopia associated with secondary defects in cerebrocortical chondroitin sulfate proteoglycans and basal lamina in MARCKS-deficient mice.	TNC NCAM1	1.88e-04	10	72	2	9184108
Pubmed	Development of heart valve leaflets and supporting apparatus in chicken and mouse embryos.	TNC COL1A1	1.88e-04	10	72	2	15162503
Pubmed	Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth.	FGFR1 COL1A1	1.88e-04	10	72	2	12756187
Pubmed	Recruitment and maintenance of tendon progenitors by TGFbeta signaling are essential for tendon formation.	TNC COL1A1	1.88e-04	10	72	2	19304887
Pubmed	Development of migrating tendon-bone attachments involves replacement of progenitor populations.	TNC COL1A1	1.88e-04	10	72	2	30504126
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	MAGEA4 PDHA1 EIF4B ZNF280C BOP1 CHD4 GPATCH8 SNRNP70 HNRNPU	2.01e-04	989	72	9	36424410
Pubmed	Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.	PTPN13 PTPRD COBL REL CSMD1	2.28e-04	265	72	5	19240061
Pubmed	Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation.	FGFR1 COL1A1	2.30e-04	11	72	2	16815385
Pubmed	Extracellular matrix protein composition dynamically changes during murine forelimb development.	TNC COL1A1	2.30e-04	11	72	2	38303699
Pubmed	A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain.	PTPN13 PTPRD	2.30e-04	11	72	2	7832766
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	HLA-B TNC EIF4B GLUL GPATCH8 COL1A1	2.39e-04	420	72	6	28065597
Pubmed	DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice.	PTPRD PLXDC2 TNC UNC93B1	2.39e-04	145	72	4	21308776
Pubmed	Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.	MPP2 PTPN13 PDHA1 GPATCH8 FRMD3	2.49e-04	270	72	5	24366813
GeneFamily	Fibronectin type III domain containing	CHL1 PTPRD TNC NCAM1 ANKFN1	1.04e-04	160	53	5	555
GeneFamily	Ankyrin repeat domain containing\|FERM domain containing	TYK2 PTPN13 FRMD3	4.23e-04	50	53	3	1293
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CHL1 PTPRD NCAM1 FGFR1	1.26e-03	161	53	4	593
Coexpression	BOQUEST_STEM_CELL_UP	CHL1 PTPN13 PTPRD TNC AGL PLTP COL1A1	6.92e-06	261	71	7	M1834
Coexpression	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP	PTPN13 ERCC6 PLXDC2 GLUL CHD4 ADAP2	1.74e-05	200	71	6	M6635
Coexpression	HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE	CYC1 CSGALNACT2 PLXDC2 HBEGF GLUL COBL BOP1 REL GNA15 UNC93B1 MED13L KIF13A COA7	2.73e-05	1250	71	13	M41099
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	TES GOPC HLA-B PLXDC2 PRRC2C BSN COA7 HNRNPU DNMT3B	3.42e-05	600	71	9	MM1025
Coexpression	RAO_BOUND_BY_SALL4	EPC2 ZNF280C COBL MIB2 FGFR1 ZCCHC7	3.45e-05	226	71	6	M2521
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	FAT4 PTPRD PRRC2C EIF4B CHD4 SNRNP70 PHLDB2 HNRNPU	3.81e-05	467	71	8	M1347
Coexpression	WELCSH_BRCA1_TARGETS_DN	CYC1 POLG BOP1 CHD4 SNRNP70	4.11e-05	141	71	5	M2428
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	FAT4 PTPRD PRRC2C EIF4B CHD4 SNRNP70 PHLDB2 HNRNPU	4.90e-05	484	71	8	MM999
Coexpression	RAO_BOUND_BY_SALL4	EPC2 ZNF280C COBL MIB2 FGFR1 ZCCHC7	5.66e-05	247	71	6	MM1081
Coexpression	BUSSLINGER_GASTRIC_PARIETAL_CELLS	CYC1 ATP6V1H PDHA1 GLUL NDUFB8 SLC4A2	6.60e-05	254	71	6	M40014
Coexpression	BURTON_ADIPOGENESIS_8	TES NCAM1 PLTP PHLDB2	6.69e-05	80	71	4	M1579
Coexpression	BURTON_ADIPOGENESIS_8	TES NCAM1 PLTP PHLDB2	7.02e-05	81	71	4	MM1021
Coexpression	GSE11386_NAIVE_VS_MEMORY_BCELL_DN	PTPN13 AGL REL ZCCHC7 KIF13A	7.06e-05	158	71	5	M372
Coexpression	SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	HBEGF GLUL GNA15 EPAS1 ADAP2	7.49e-05	160	71	5	M986
Coexpression	MODY_HIPPOCAMPUS_NEONATAL	CHL1 TNC NCAM1	8.93e-05	32	71	3	MM657
Coexpression	MODY_HIPPOCAMPUS_NEONATAL	CHL1 TNC NCAM1	9.80e-05	33	71	3	M7409
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL	TYK2 PTPRD HLA-B PLXDC2 TNC HBEGF COBL ZNF317 PLTP FRMD3 SLC4A2	1.18e-04	1054	71	11	M45798
Coexpression	FOSTER_TOLERANT_MACROPHAGE_DN	PTPRD TNC HBEGF REL GNA15 MED13L ADAP2	1.38e-04	418	71	7	M12676
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	TES PLXDC2 TNC HBEGF GLUL NCAM1 PHLDB2 DNMT3B COL1A1	1.39e-04	721	71	9	M1999
Coexpression	JISON_SICKLE_CELL_DISEASE_DN	PRRC2C POLG EIF4B GPATCH8 SNRNP70	1.52e-04	186	71	5	M4911
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	TES GOPC PLXDC2 PRRC2C BSN COA7 HNRNPU DNMT3B	1.60e-04	574	71	8	M8215
Coexpression	FOSTER_TOLERANT_MACROPHAGE_DN	PTPRD TNC HBEGF REL GNA15 MED13L ADAP2	1.76e-04	435	71	7	MM1221
Coexpression	HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE	PLXDC2 BOP1 REL GNA15 MED13L KIF13A COA7	1.76e-04	435	71	7	M41115
Coexpression	GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP	ATP6V1H HBEGF GNA15 EPAS1 SLC4A2	2.08e-04	199	71	5	M8371
Coexpression	GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN	CYC1 PPP2R2A ATP6V1H PDHA1 SLC4A2	2.08e-04	199	71	5	M6612
Coexpression	GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP	TNC NCAM1 PLTP EPAS1 PHLDB2	2.13e-04	200	71	5	M6459
Coexpression	GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN	TES AGL CIR1 UNC93B1 EPAS1	2.13e-04	200	71	5	M6247
Coexpression	GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN	POLG GNA15 NDUFB8 PLTP SLC4A2	2.13e-04	200	71	5	M7653
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING	CYB5D2 ERCC6 HLA-B CHD4 GPATCH8 MED13L BSN PLTP PHLDB2 COL1A1	2.40e-04	954	71	10	MM3689
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	PTPN13 PTPRD PLXDC2 KIF13A FRMD3	2.79e-04	212	71	5	M39221
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPN13 PTPRD PLXDC2 TNC FRMD3 COL1A1	2.42e-08	189	72	7	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CHL1 FAT4 PLXDC2 TNC NCAM1 PLTP COL1A1	3.32e-08	198	72	7	7582ee9ec8a87ecb094201f1f9191b412f9d2875
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 PLXDC2 TNC NCAM1 PLTP COL1A1	4.73e-07	180	72	6	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CSGALNACT2 PLXDC2 PRRC2C REL MED13L CSMD1	5.74e-07	186	72	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC FRMD3 COL1A1	6.50e-07	190	72	6	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PLXDC2 HBEGF GLUL GNA15 MED13L ADAP2	6.90e-07	192	72	6	f14ee74ac3275601749a23c5efe39c2413a62e1a
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	PTPN13 PLXDC2 TNC EPAS1 FRMD3 COL1A1	6.90e-07	192	72	6	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPN13 PTPRD PLXDC2 TNC COL1A1	6.90e-07	192	72	6	ee085e04d5dcfb657522484ed20b8c1ddeccfe0c
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLXDC2 HBEGF GLUL GNA15 MED13L ADAP2	6.90e-07	192	72	6	0219093e7921a0db78053aee13ec480b520f5662
ToppCell	(1)_Osterolineage_cells\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	PTPRD TNC NCAM1 FGFR1 PLTP COL1A1	7.12e-07	193	72	6	035eeea9f77c4bf9cd85f07fa791b6c857be76b5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC FRMD3 COL1A1	7.34e-07	194	72	6	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	facs-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CSGALNACT2 PLXDC2 PRRC2C GLUL FGFR1 COL1A1	7.56e-07	195	72	6	c4648c0332c3826776f9ad3f5f803dbac2b4c0c0
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CHL1 PTPRD PLXDC2 TNC BSN COL1A1	8.02e-07	197	72	6	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	FAT4 PTPRD CSGALNACT2 PLXDC2 TNC COL1A1	8.02e-07	197	72	6	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	PRRC2C HBEGF GLUL REL MED13L HNRNPU	8.26e-07	198	72	6	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)\|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLXDC2 HBEGF GLUL PLTP EPAS1 ADAP2	8.26e-07	198	72	6	ff9c97c6f579a4e79859d420f224556fadc1f6ab
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CHL1 PTPRD PLXDC2 TNC FRMD3 COL1A1	8.51e-07	199	72	6	c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRD PLXDC2 TNC NCAM1 PLTP COL1A1	8.51e-07	199	72	6	2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRD PLXDC2 TNC NCAM1 PLTP COL1A1	8.51e-07	199	72	6	9e87b64e16d595701c3beb07aa835afe3330bd10
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	PLXDC2 TNC GLUL NCAM1 PLTP COL1A1	8.51e-07	199	72	6	56d72da6a5fab9cbb2975fe6f87a631debaba6a8
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	CHL1 PTPRD PLXDC2 TNC FRMD3 COL1A1	8.76e-07	200	72	6	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 PTPRD PLXDC2 TNC FGFR1 COL1A1	8.76e-07	200	72	6	a4ec0e80f5422b91b85264a9bb74568dd577e285
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	PRRC2C EIF4B CHD4 PHLDB2 HNRNPU COL1A1	8.76e-07	200	72	6	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	CHL1 PTPRD PLXDC2 TNC FRMD3 COL1A1	8.76e-07	200	72	6	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CHL1 PTPRD PLXDC2 TNC FRMD3 COL1A1	8.76e-07	200	72	6	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	normal_Lung-T/NK_cells-Exhausted_Tfh\|T/NK_cells / Location, Cell class and cell subclass	PTPN13 TNC REL GNA15 EPAS1	9.27e-06	174	72	5	e324320b52c904496e26fcecfa179b3431729ec0
ToppCell	P03-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PTPRD PLXDC2 PLTP EPAS1 COL1A1	9.53e-06	175	72	5	282f09bbdfa70d93b3f66591dcfb84c5ee0268c7
ToppCell	facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CHL1 TYK2 ERCC6 MEIOC NCAM1	9.53e-06	175	72	5	bb898796662b97f7459b7dda7cecf6a9bde8b055
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HBEGF GNA15 UNC93B1 PLTP ADAP2	9.53e-06	175	72	5	c9dc6aa652ac887470806a950311657c423d9495
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 TNC HBEGF NCAM1 CSMD1	1.09e-05	180	72	5	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 TNC HBEGF NCAM1 CSMD1	1.09e-05	180	72	5	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHL1 TNC HBEGF NCAM1 CSMD1	1.09e-05	180	72	5	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	FAT4 PTPRD PLXDC2 NCAM1 COL1A1	1.15e-05	182	72	5	ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PTPRD PLXDC2 TNC NCAM1 COL1A1	1.25e-05	185	72	5	9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CHL1 PTPRD PLXDC2 TNC COL1A1	1.25e-05	185	72	5	1ac6a32cc56d5d819649bdd99518e2ead0eead4c
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CNTNAP3B FAT4 CNTNAP3 CSMD1 EPAS1	1.25e-05	185	72	5	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	Mesenchymal_cells-Adipo-CAR\|World / Lineage and Cell class	PTPRD PLXDC2 TNC CSMD1 EPAS1	1.28e-05	186	72	5	6ca8ce7ced91d6308b7c056032ffec1b37c974bf
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PTPRD PLXDC2 TNC NCAM1 COL1A1	1.31e-05	187	72	5	13731298bc562ec29582f5da1b4c97261284f6f1
ToppCell	normal_Lymph_Node-Myeloid_cells-mo-Mac\|normal_Lymph_Node / Location, Cell class and cell subclass	PLXDC2 HBEGF GLUL PLTP ADAP2	1.35e-05	188	72	5	e83de94a9b47a6a90e98face887eae031a322af6
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	PTPRD PLXDC2 TNC NCAM1 COL1A1	1.35e-05	188	72	5	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	droplet-Limb_Muscle-nan-3m-Mesenchymal-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXDC2 GLUL NCAM1 FGFR1 COL1A1	1.35e-05	188	72	5	7191087d8754f5e8700e3d744cd920ee26db1e57
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HBEGF GLUL GNA15 PLTP ADAP2	1.35e-05	188	72	5	cb091912f9b627a78a8793a37df7f1de839f887f
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD PLXDC2 TNC FGFR1 COL1A1	1.38e-05	189	72	5	32e6d6285b258831b965281224ff2aaeecdcb5f5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.38e-05	189	72	5	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PTPRD PLXDC2 TNC NCAM1 COL1A1	1.38e-05	189	72	5	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRD PLXDC2 TNC FGFR1 COL1A1	1.38e-05	189	72	5	385ef7bbd76c8047aeecf6542377d4213b5da5db
ToppCell	Control-Myeloid-Transitioning_MDM\|Control / group, cell type (main and fine annotations)	PLXDC2 GLUL REL GNA15 PLTP	1.42e-05	190	72	5	d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TNC CHD4 EPAS1 PHLDB2 HNRNPU	1.42e-05	190	72	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.42e-05	190	72	5	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.42e-05	190	72	5	d60395739458d7f47a3350ade751fe3819500320
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.45e-05	191	72	5	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-MMP9+_Inflammatory_macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-B GLUL GNA15 PLTP ADAP2	1.45e-05	191	72	5	87b974a320888d63aa8cefcd8dc97d525b56d848
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.49e-05	192	72	5	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PLXDC2 TNC FRMD3 COL1A1	1.49e-05	192	72	5	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPN13 PTPRD TNC COL1A1	1.49e-05	192	72	5	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 NRAP PTPRD EPAS1 COL1A1	1.49e-05	192	72	5	be75783d9578974b662e1cb13bd3442a921fd50a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.49e-05	192	72	5	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.49e-05	192	72	5	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.49e-05	192	72	5	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	facs-Marrow-KLS-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 NRAP PTPRD EPAS1 COL1A1	1.49e-05	192	72	5	4fc98f30f8e738816cd93101fbe8ac40889e302a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.49e-05	192	72	5	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXDC2 PRRC2C GLUL HNRNPU ADAP2	1.53e-05	193	72	5	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXDC2 PRRC2C GLUL HNRNPU ADAP2	1.53e-05	193	72	5	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXDC2 PRRC2C GLUL HNRNPU ADAP2	1.53e-05	193	72	5	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.53e-05	193	72	5	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXDC2 PRRC2C GLUL HNRNPU ADAP2	1.53e-05	193	72	5	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_RSPO2+\|Trachea / Age, Tissue, Lineage and Cell class	FAT4 PTPRD PLXDC2 TNC COL1A1	1.57e-05	194	72	5	8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.57e-05	194	72	5	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CHL1 PTPRD PLXDC2 TNC COL1A1	1.57e-05	194	72	5	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXDC2 PRRC2C GLUL NCAM1 FGFR1	1.61e-05	195	72	5	4d63e0dca30ae57960459d2fbcba09122273e37b
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 PLXDC2 FGFR1 PHLDB2 COL1A1	1.61e-05	195	72	5	f54bc4454270ff06e85596f98199372b50d0179f
ToppCell	(3)_Chondrocytes-(30)_Chondro\|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis	FAT4 GLUL FGFR1 PLTP COL1A1	1.61e-05	195	72	5	f5597d3ed37770c6fa2b339f98a80ac7ecd4f9ff
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXDC2 PRRC2C GLUL NCAM1 FGFR1	1.61e-05	195	72	5	661af601a3561fe3aacf2444ad7b8927fa88b48a
ToppCell	3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HBEGF GLUL GNA15 PLTP ADAP2	1.61e-05	195	72	5	028622b234551b185977fbee10c06851a45456a5
ToppCell	droplet-Kidney-nan-3m-Epithelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CYC1 PTPRD PDHA1 NDUFB8 PHLDB2	1.65e-05	196	72	5	9f39cb3de886283da34ee7511a92d94930a6c851
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRD PLXDC2 TNC FGFR1 COL1A1	1.65e-05	196	72	5	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	(3)_MNP\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	PLXDC2 HBEGF GLUL GNA15 ADAP2	1.65e-05	196	72	5	c79403da5443710a6caf035a279e42bc324b27c9
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSGALNACT2 PLXDC2 GLUL FGFR1 COL1A1	1.65e-05	196	72	5	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSGALNACT2 PLXDC2 GLUL FGFR1 COL1A1	1.65e-05	196	72	5	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	PND07-Mesenchymal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRD PLXDC2 TNC FGFR1 COL1A1	1.65e-05	196	72	5	0050c7134473fbfd7b9f0ae8d6d337713e60b57d
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-basal_cell_of_epidermis\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNC PRRC2C EIF4B GLUL PLTP	1.65e-05	196	72	5	d4df86ce289835e76763213641989fde77935a16
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HLA-B HBEGF GNA15 PLTP ADAP2	1.69e-05	197	72	5	759f26753f76af3ae8d8527c4d221206245a3d45
ToppCell	MatrixFB\|World / shred on cell class and cell subclass (v4)	PTPRD PLXDC2 TNC FGFR1 COL1A1	1.69e-05	197	72	5	e325de44e32021a36fffb7b7e88167b46bb051c7
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CNTNAP3B PLXDC2 CNTNAP3 FGFR1 FRMD3	1.69e-05	197	72	5	f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e
ToppCell	PND01-Mesenchymal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PTPRD PLXDC2 TNC FGFR1 COL1A1	1.69e-05	197	72	5	292b8cc3dafddf5d323fe4e3d3ea5ac61e6ce027
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CHL1 PTPRD PLXDC2 TNC COL1A1	1.73e-05	198	72	5	0a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HBEGF GLUL GNA15 PLTP ADAP2	1.73e-05	198	72	5	acb84681569651447d684aa3960f0510d7ff17e8
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLXDC2 HBEGF GLUL PLTP ADAP2	1.73e-05	198	72	5	e1a0c809302a3b304775bd708201ad412a98d711
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PTPRD TNC NCAM1 FGFR1 COL1A1	1.73e-05	198	72	5	9d61483b0decac2fe90045b3474843360b2c49b3
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PTPRD TNC NCAM1 FGFR1 COL1A1	1.73e-05	198	72	5	6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f
ToppCell	Smart-seq2-thymus_(Smart-seq2)-myeloid\|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	HLA-B HBEGF GLUL PLTP ADAP2	1.73e-05	198	72	5	2e470249edc7cf85bed550795ff84cbef22895c0
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PTPN13 PTPRD TNC NCAM1 COL1A1	1.73e-05	198	72	5	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 PTPN13 TNC GNA15 EPAS1	1.73e-05	198	72	5	19d8ff3a4f911b13ecc34844202925475ad4d2ab
ToppCell	mild-HLA-DR-_S100A+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	PLXDC2 HBEGF GLUL KIF13A ADAP2	1.77e-05	199	72	5	d0d286eafe935f9b3aaba5b783e8911251121b4a
ToppCell	Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CHL1 PTPN13 TNC CSMD1 EPAS1	1.77e-05	199	72	5	94a7867e800df352731796de8c24cba133c29622
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLXDC2 HBEGF GLUL PLTP ADAP2	1.77e-05	199	72	5	0d447ca1a77120aac068857ff0ddc2ed6942ed3e
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PTPRD TNC NCAM1 FGFR1 COL1A1	1.77e-05	199	72	5	7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CHL1 PTPRD PLXDC2 TNC COL1A1	1.77e-05	199	72	5	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-myeloid\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PLXDC2 HBEGF GLUL PLTP ADAP2	1.77e-05	199	72	5	0f3ce61bbae69f7e333ed8dacf7257645624e163
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLXDC2 HBEGF REL PLTP ADAP2	1.77e-05	199	72	5	5a291fa161c37ec31e9c43d9b3075c3e06333261
Disease	contact dermatitis	FLG FGFR1	1.71e-05	3	71	2	EFO_0005319
Disease	estrogen measurement, response to aromatase inhibitor	MPP2 CSMD1	5.68e-05	5	71	2	EFO_0011007, GO_0061477
Disease	otosclerosis (is_implicated_in)	HLA-B COL1A1	8.51e-05	6	71	2	DOID:12185 (is_implicated_in)
Disease	lung cancer (is_marker_for)	ERCC6 TNC DNMT3B	1.15e-04	39	71	3	DOID:1324 (is_marker_for)
Disease	autosomal recessive intellectual developmental disorder (implicated_via_orthology)	CNTNAP3B CNTNAP3	1.58e-04	8	71	2	DOID:0060308 (implicated_via_orthology)
Disease	lung adenocarcinoma (is_implicated_in)	PTPN13 CHD4 DNMT3B	2.27e-04	49	71	3	DOID:3910 (is_implicated_in)
Disease	monoclonal gammopathy	PTPRD TNC CSMD1	2.87e-04	53	71	3	EFO_0000203
Disease	NG-monomethyl-arginine measurement	CSMD1 ANKFN1	3.10e-04	11	71	2	EFO_0010510
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	CDC25A SLC4A2	3.10e-04	11	71	2	DOID:0110861 (biomarker_via_orthology)
Disease	facial morphology	CSMD1 EPAS1 PHLDB2	3.20e-04	55	71	3	EFO_0004743
Disease	Psoriasis	TYK2 REL CSMD1	3.56e-04	57	71	3	C0033860
Disease	Pustulosis of Palms and Soles	TYK2 REL CSMD1	3.56e-04	57	71	3	C0030246
Disease	Modic type vertebral endplate changes	MPP2 PTPRD	4.38e-04	13	71	2	HP_0030775
Disease	pulse pressure measurement	EPC2 PTPRD GOPC HLA-B PLXDC2 NCAM1 GPATCH8 MED13L CDC25A SNRNP70 DNMT3B	4.69e-04	1392	71	11	EFO_0005763
Disease	cerebellum cortex volume change measurement	PTPRD EPAS1	5.10e-04	14	71	2	EFO_0021497
Disease	head and neck squamous cell carcinoma (is_implicated_in)	PTPN13 DNMT3B	5.87e-04	15	71	2	DOID:5520 (is_implicated_in)
Disease	myocardial infarction (biomarker_via_orthology)	TNC NCAM1 EPAS1 COL1A1	6.10e-04	160	71	4	DOID:5844 (biomarker_via_orthology)
Disease	Dermatitis	FLG HLA-B	6.70e-04	16	71	2	C0011603
Disease	allergic disease, age at onset	FLG HLA-B FGFR1	6.79e-04	71	71	3	EFO_0004847, MONDO_0005271
Disease	Hereditary Diffuse Gastric Cancer	FAT4 PDHA1 HBEGF BOP1 DNMT3B	7.11e-04	293	71	5	C1708349
Disease	Mood Disorders	POLG GLUL NCAM1 DNMT3B	7.32e-04	168	71	4	C0525045
Disease	Stomach Neoplasms	FAT4 PDHA1 HBEGF BOP1 DNMT3B	7.56e-04	297	71	5	C0038356
Disease	QRS duration	MPP2 FAT4 PTPRD NCAM1 EPAS1	7.67e-04	298	71	5	EFO_0005055
Disease	Malignant neoplasm of stomach	FAT4 PDHA1 HBEGF BOP1 DNMT3B	7.91e-04	300	71	5	C0024623
Disease	polycystic kidney disease (biomarker_via_orthology)	TNC EPAS1	9.51e-04	19	71	2	DOID:0080322 (biomarker_via_orthology)
Disease	pulmonary hypertension (biomarker_via_orthology)	TNC EPAS1 COL1A1	9.60e-04	80	71	3	DOID:6432 (biomarker_via_orthology)
Disease	amino acid measurement	TYK2 MPP2 FAT4 CNTNAP3 COBL CSMD1 EPAS1	1.22e-03	678	71	7	EFO_0005134
Disease	chronotype measurement	EPC2 PTPRD CIR1 ZCCHC7 MED13L CSMD1 BSN ANKFN1	1.25e-03	882	71	8	EFO_0008328
Disease	Schizophrenia	CHL1 HLA-B GLUL NCAM1 CHD4 FGFR1 CSMD1 DNMT3B	1.25e-03	883	71	8	C0036341
Disease	atopic asthma	FLG HLA-B GNA15 FGFR1	1.37e-03	199	71	4	EFO_0010638
Disease	sensory peripheral neuropathy, remission	MPP2 CSMD1	1.40e-03	23	71	2	EFO_0009785, MONDO_0002321
Disease	airway responsiveness measurement	CSMD1 ANKFN1	1.52e-03	24	71	2	EFO_0006897
Disease	alpha-2-macroglobulin receptor-associated protein measurement	HLA-B LINC01556	1.52e-03	24	71	2	EFO_0008021
Disease	Left Ventricular Hypertrophy	HBEGF COL1A1	1.65e-03	25	71	2	C0149721
Disease	Heart valve disease	FGFR1 COL1A1	1.79e-03	26	71	2	C0018824
Disease	obesity (implicated_via_orthology)	TYK2 FAT4 GLUL MED13L	1.82e-03	215	71	4	DOID:9970 (implicated_via_orthology)
Disease	tuberculosis	TES PTPRD POLG CSMD1	1.85e-03	216	71	4	MONDO_0018076
Disease	gastroesophageal reflux disease	HLA-B NCAM1 CSMD1	1.88e-03	101	71	3	EFO_0003948
Disease	azoospermia (implicated_via_orthology)	PTPRD GOPC	1.93e-03	27	71	2	DOID:14227 (implicated_via_orthology)
Disease	susceptibility to rheumatic fever measurement	PTPRD CDC25A	2.07e-03	28	71	2	EFO_0008416
Disease	Strabismus	PTPRD CSMD1	2.22e-03	29	71	2	HP_0000486
Disease	unipolar depression	PTPRD HLA-B TNC CIR1 NCAM1 ZCCHC7 CSMD1 LINC01556 ZNF417	2.36e-03	1206	71	9	EFO_0003761
Disease	cervical cancer (is_implicated_in)	HLA-B CDC25A	2.38e-03	30	71	2	DOID:4362 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
DFPHVGYDLDGRRIY	BOP1	146	Q14137
GYHPEELLGRSAYEF	EPAS1	266	Q99814
KRYHLGDYGGEILNE	EPC2	271	Q52LR7
EPGRSYGEEDFEYHR	SLC4A2	61	P04920
KHRGNPSGLYYIDAD	CNTNAP3	596	Q9BZ76
GIPNYGYRIRDEGHF	CSMD1	1221	Q96PZ7
YHLLNYSRPKEGDDR	DNMT3B	676	Q9UBC3
PEGYNLKEEDGRYRD	PPP2R2A	131	P63151
AFYAGLRRPHEGYEV	C1QL4	111	Q86Z23
EDNYGARLKPRRYHG	FAT4	4881	Q6V0I7
DLSYIVRARHGGEDY	CYC1	196	P08574
RKGYSPTHREEEYGK	FLG	161	P20930
GRKVGRYRDDGDEDY	ERCC6	446	Q03468
YEAYEDLPKGIRGNR	ADAP2	311	Q9NPF8
ESGHRYRLYLDELEG	GOPC	386	Q9HD26
GRKVGRYRDDGDEDY	ERCC6	446	P0DP91
ARVEDGKGYYREPCA	HOXC12	86	P31275
RLLLDPYGGHRDVAY	MED13L	1406	Q71F56
VYDGREHTVYGEPRK	MAGEA4	231	P43358
EEVKPLEGRRYHIYE	CHL1	461	O00533
QGYPEEYEEHRGKGS	NRAP	296	Q86VF7
VVDVGGEYDPRRHRY	MYG1	91	Q9HB07
NIYSDHRYGPRGDAV	BSN	2066	Q9UPA5
GDSDYRHGARVEKYG	BSN	3321	Q9UPA5
DGPRAHAYKREEGYI	BSN	3546	Q9UPA5
KREEGAGATEPEYYH	GPATCH8	381	Q9UKJ3
IPDLRGKEGHFYYNI	PLTP	51	P55058
VKRPREDHGRGYFEY	HNRNPU	246	Q00839
IRHPDYDEEGLYGAI	POLG	826	P54098
RAGRYLEHGEYEGNL	MPP2	436	Q14168
HGAGYSEEERKGFRP	GNA15	66	P30679
GYGDYPKLPDRSQHE	NDUFB8	71	O95169
GRLLRGHDQYAYDGK	HLA-B	131	P01889
PGKSVLFRDYGLYDH	METTL6	181	Q8TCB7
DYFGIRYVDPEKQRH	FRMD3	71	A2A2Y4
GGEDVHLYRKYLHGD	CSGALNACT2	456	Q8N6G5
EFKPDHRIGGYKVRY	FGFR1	196	P11362
VRPHGYAEKGYAGKA	COBL	886	O75128
YHRRGGYDVENEEKV	HBEGF	186	Q99075
LEHEGYKYERIDGGI	CHD4	1086	Q14839
GRRYIYESPNHRGKD	LINC01556	41	Q5JQF7
KHRGNPSGLYYIDAD	CNTNAP3B	596	Q96NU0
RYPYEYEGGHIKGAV	CDC25A	386	P30304
RERDRLGNEYPKLHY	CDC25A	446	P30304
NVEEPVRRYKTYHGD	PTPN13	396	Q12923
RYGREVELKPYIAAH	PTPRD	1181	P23468
YPPRRGDDSFGDKYR	EIF4B	211	P23588
EAAGGFYYKDHLPRL	MIB2	226	Q96AX9
RLYGKRGDPFYEAQE	KIF13A	771	Q9H1H9
GADRAYGRDIVEAHY	GLUL	166	P15104
GKPRGYAFIEYEHER	SNRNP70	141	P08621
KESGVDIYHYGRDRI	MEIOC	281	A2RUB1
AHDVGEYVRHYPRGK	ATP6V1H	411	Q9UI12
GDPAIYAERAGYDKL	TES	246	Q9UGI8
GRGHTRDYPQYRDNK	PRRC2C	1211	Q9Y520
KFRRGSGHPAYAEVE	PLXDC2	501	Q6UX71
GRVYDVSSGRRHYEP	CYB5D2	61	Q8WUJ1
YPLGRADFDHYTGRD	PHLDB2	121	Q86SQ0
GRVYYEPIKDRHGNI	ANKFN1	531	Q8N957
TDLYRGEKMYREHPG	CIR1	426	Q86X95
DGQPDLGKARDYYTR	COA7	126	Q96BR5
QEKAHDGGRYYRADD	COL1A1	1206	P02452
DDGGSPIRHYLVRYR	NCAM1	636	P13591
GHSGERPYECGEYRK	ZNF586	81	Q9NXT0
RPQHKVRGYRYLEED	UNC93B1	531	Q9H1C4
DYYKRGDFIPGLRVD	PDHA1	241	P08559
RYSRDHVVEGEPYAG	FAM20B	126	O75063
DSYRIKYAPISGGDH	TNC	921	P24821
RVHTGERPYECREYG	ZNF417	316	Q8TAU3
RDHTGREPNEYQEYG	ZNF627	121	Q7L945
PHDLVGKDCRDGYYE	REL	76	Q04864
KGHYGHECPEREVYD	ZCCHC7	356	Q8N3Z6
EFYYGRHEGVTEKEP	ZNF280C	296	Q8ND82
GRHAGKRPYHRRDYG	ZNF317	186	Q96PQ6
KRPYHRRDYGVAFKG	ZNF317	191	Q96PQ6
KAVPEGHEYYRVRED	TYK2	1046	P29597
GHEYYRVREDGDSPV	TYK2	1051	P29597
SHEEGRLVYRYGGEP	AGL	586	P35573